Stay updated on First-Line Atezolizumab Combos in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the First-Line Atezolizumab Combos in Head and Neck Clinical Trial page.

Latest updates to the First-Line Atezolizumab Combos in Head and Neck Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded: Results Submitted and Revision: v3.5.2; removed: No Results Posted and Revision: v3.5.0.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck as a condition and included the Genetic and Rare Diseases Information Center as a related resource.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. There are no changes to the study data, eligibility criteria, outcomes, or listed locations.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the previous Revision: v3.4.1.SummaryDifference0.3%

Stay in the know with updates to First-Line Atezolizumab Combos in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the First-Line Atezolizumab Combos in Head and Neck Clinical Trial page.